Persistent genital arousal disorder

Persistent genital arousal disorder (PGAD), previously called persistent sexual arousal syndrome,[1] is spontaneous, persistent, unwanted and uncontrollable genital arousal in the absence of sexual stimulation or sexual desire,[2][3] and is typically not relieved by orgasm.[3][4] Instead, multiple orgasms over hours or days may be required for relief.[4]

Persistent genital arousal disorder
Other namesPGAD
SpecialtySexology, neurology Edit this on Wikidata

PGAD occurs in people of all sexes.[5][4][6] It has been compared to priapism in male and female genitalia.[6][7] PGAD is rare and is not well understood.[2][4] The literature is inconsistent with the nomenclature. It is distinguished from hypersexuality, which is characterized as heightened sexual desire.[1][4]

Classification

In 2003, "persistent genital arousal" was considered for inclusion with regard to the International Consultation on Sexual Medicine (ICSM). In 2009, "persistent genital arousal dysfunction" was included in its third edition.[4] PGAD is not included in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) or the International Classification of Diseases (ICD-10), which may be due to the disorder requiring further research.[4]

The condition has been characterized by a researcher as being a term with no scientific basis.[8] There is concern that the title may be misleading because, since the genital arousal is unwanted, it is dubious to characterize it as arousal.[8]

Other researchers have suggested that the disorder be renamed "persistent genital vasocongestion disorder (PGVD)"[9] or "restless genital syndrome (ReGS)."[9][10]

Signs and symptoms

Physical arousal caused by PGAD can be very intense and persist for extended periods, days, weeks or years at a time.[3][4] Symptoms may include pressure, pain, vibrating, pleasure, irritation, clitoral or penile[5] tingling, throbbing, vaginal congestion, vaginal contractions, penile spasms, arousal, clitoral or penile erections, and prolonged spontaneous orgasms.[3] Pressure, pleasure, discomfort, pounding, pulsating, throbbing or engorgement may include the clitoris, penis, labia, vagina, perineum, or the anus.[11] The symptoms may result from sexual activity or from no identified stimulus, and are not relieved by a single orgasm, instead multiple strong orgasms over hours, days or weeks are needed for short term relief.[4] The symptoms can impede on home or work life.[3][9] Women and men[5] may feel embarrassment or shame, and avoid sexual relationships, because of the disorder.[3][4] Stress can make the symptoms worse.[9][11]

Cause

Researchers do not know the cause of PGAD, but assume that it has neurological, vascular, pharmacological, and psychological causes.[1][4] Tarlov cysts have been speculated as a cause.[3][11] PGAD has been associated with clitoral priapism,[12] and has been compared to priapism in men.[6][7] It is also similar to vulvodynia, in that the causes for both are not well understood, both last for a long time, and women with either condition may be told that it is psychological rather than physical.[3] It has been additionally associated with restless legs syndrome (RLS), but a minority of women with PGAD have restless legs syndrome,[9] as with men as well.

In some recorded cases, the syndrome was caused by or can cause a pelvic arterial-venous malformation with arterial branches to the clitoris.[11][13] Surgical treatment was effective in this instance.[13] There is evidence that some drugs such as SSRIs and SNRIs might induce or worsen PGAD.[14]

Diagnosis

The following five criteria must be met by patients in order to be diagnosed with PGAD:[15][16]

  1. Typical physiological responses from sexual arousal persist for an extended amount of time and do not cease on their own
  2. Feelings of arousal remain even after orgasm or multiple orgasms are needed to lessen the arousal
  3. Arousal is experienced without desire or sexual excitement
  4. Arousal occurs with both sexual and non-sexual stimuli or with no stimuli
  5. Symptoms are intrusive, unwanted, and cause distress

Treatment

Because PGAD has only been researched since 2001, there is little documenting what may cure or remedy the disorder.[4] Treatment may include extensive psychotherapy, psycho-education, and pelvic floor physical therapy.[4][9] In one case, serendipitous relief of symptoms was concluded from treatment with varenicline, a treatment for nicotine addiction.[4] It was reported in a study that repeated masturbation (51%), strong or prolonged orgasms (50%), distraction (39%), intercourse (36%), exercise (25%), and cold compresses (13%) were the most relieving treatments that could be done without the help of a professional.[17]

Having a team of professionals such as a medical provider, a pelvic floor physical therapist, message therapist and sex therapist has been shown to aid patients. One study found that after working with professionals patients felt validated, listened to, and that their sexual function had improved.[15] Many patients felt practicing mindfulness allowed them to adjust to living with PGAD by recognizing thoughts and emotions corresponding to the symptoms and avoiding brooding over them.[17] This treatment method focuses on reducing the anxiety that is caused by the condition and pushes the patient to develop effective distraction and relaxation techniques.[16]

Epidemiology

PGAD is very rare and is believed to affect about 1% of women,[15] and is considered even more rare in men.[5] Although online surveys have indicated that hundreds of women and men[5] may have PGAD,[4] documented case studies have been limited.[18][19][20]

History

The earliest references to PGAD may be Greek descriptions of hypersexuality (previously known as "satyriasis" and "nymphomania"), which confused persistent genital arousal with sexual insatiability.[4] While PGAD involves the absence of sexual desire, hypersexuality is characterized as heightened sexual desire.[1][4]

The term persistent sexual arousal syndrome was coined by researchers Leiblum and Nathan in 2001.[1][3] In 2006, Leiblum renamed the condition to "persistent genital arousal disorder" to indicate that genital arousal sensations are different from those that result from true sexual arousal.[1] The rename was also considered to give the condition a better chance of being classified as a dysfunction.[1] Now PGAD is often called or termed Genito-Pelvic Dysesthesia.[21]

Impact on mental health

Women and men[21] with PGAD report having unstable mental health with thoughts of suicide and difficulty completing daily activities.[22][23] Most people that suffer from PGAD report having to masturbate 6, 20 or even more times a day and may have to use many types of sexual devices to experience any type of relief from symptoms.[24] Many people are afraid to leave their homes due to fears that PGAD symptoms may flare up while in public and they will not be able to wait until they are able to relieve themselves.[24]

Before the start of their PGAD, many women were seen to have higher stress scores as well as symptoms of depression and anxiety.[23] Panic attacks (31.6%) and major depression (57.9%) were reported commonalities between patients occurring at least one year prior to the onset of PGAD symptoms. Up to 45% of women and men with the disorder have reported having a history with antidepressants.[17][21]

A small study found that several women and men began to see symptoms of PGAD after discontinuing the use of their selective serotonin reuptake inhibitors.[21] It is not known whether reintroduction of the SSRIs would improve PGAD symptoms.[22]

See also

References
  1. Richard Balon; Robert Taylor Segraves (2009). Clinical Manual of Sexual Disorders. American Psychiatric Pub. p. 193. ISBN 978-1-58562-905-3. Retrieved February 8, 2018.
  2. Gerald L. Andriole (2013). Year Book of Urology 2013, E-Book. Elsevier Health Sciences. p. 160. ISBN 978-1-4557-7316-9. Retrieved February 8, 2018.
  3. David A. Gordon; Mark R. Katlic (2017). Pelvic Floor Dysfunction and Pelvic Surgery in the Elderly: An Integrated Approach. Springer. p. 259. ISBN 978-1-4939-6554-0. Retrieved February 8, 2018.
  4. Brian A. Sharpless (2016). Unusual and Rare Psychological Disorders: A Handbook for Clinical Practice and Research. Oxford University Press. pp. 110–120. ISBN 978-0-19-024586-3. Retrieved February 8, 2018.
  5. "Male PGAD". www.pelvicrehabilitation.com.
  6. Kevan R. Wylie (2015). ABC of Sexual Health. John Wiley & Sons. p. 52. ISBN 978-1-118-66556-5. Retrieved February 8, 2018.
  7. Sandra R. Leiblum (2006). Principles and Practice of Sex Therapy, Fourth Edition. Guilford Press. p. 60. ISBN 1-60623-827-2. Retrieved October 14, 2019.
  8. Puppo, Vincenzo; Puppo, Giulia (2015). "Anatomy of sex: Revision of the new anatomical terms used for the clitoris and the female orgasm by sexologists". Clinical Anatomy. 28 (3): 293–304. doi:10.1002/ca.22471. ISSN 1098-2353. PMID 25283533. S2CID 1981499. Also, female ejaculation, premature ejaculation, persistent genital arousal disorder (PGAD), periurethral glans, vaginal-cervical genitosensory component of the vagus nerve, and G-spot amplification, are terms without scientific basis.
  9. Anna Padoa; Talli Y. Rosenbaum (2009). The Overactive Pelvic Floor. Springer. p. 25. ISBN 978-3-319-22150-2. Retrieved February 8, 2018.
  10. Stetka, Bret S.; De Aquino, Camila Henriques (March 3, 2015). "What Is Restless Genital Syndrome?". Medscape. Retrieved February 8, 2018.
  11. Kevan R. Wylie (2015). ABC of Sexual Health. John Wiley & Sons. p. 39. ISBN 978-1-118-66556-5. Retrieved February 8, 2018.
  12. Helen Carcio; R. Mimi Secor (2014). Advanced Health Assessment of Women, Third Edition: Clinical Skills and Procedures. Springer Publishing Company. p. 85. ISBN 978-0-8261-2309-1. Retrieved February 8, 2018.
  13. Goldstein, Irwin (1 March 2004). "Persistent Sexual Arousal Syndrome". Boston University Medical Campus Institute for Sexual Medicine. Retrieved 2007-05-04.
  14. Kruger, Tillmann H. C.; Schippert, Cordula; Meyer, Bernhard (2020-03-01). "The Pharmacotherapy of Persistent Genital Arousal Disorder". Current Sexual Health Reports. 12 (1): 34–39. doi:10.1007/s11930-020-00240-0. ISSN 1548-3592.
  15. Klifto, Kevin M.; Dellon, A. Lee (April 2020). "Persistent Genital Arousal Disorder: Review of Pertinent Peripheral Nerves". Sexual Medicine Reviews. 8 (2): 265–273. doi:10.1016/j.sxmr.2019.10.001. ISSN 2050-0521. PMID 31704111. S2CID 207938858.
  16. Leiblum, Sandra; Nathan, Sharon (2002-05-01). "Persistent sexual arousal syndrome in women: A not uncommon but little recognized complaint". Sexual and Relationship Therapy. 17 (2): 191–198. doi:10.1080/14681990220121301. ISSN 1468-1994. S2CID 144785991.
  17. Facelle, Thomas M.; Sadeghi-Nejad, Hossein; Goldmeier, David (February 2013). "Persistent genital arousal disorder: characterization, etiology, and management". The Journal of Sexual Medicine. 10 (2): 439–450. doi:10.1111/j.1743-6109.2012.02990.x. ISSN 1743-6109. PMID 23157369.
  18. r. Leiblum, Sharon g. Nathan; Nathan, S. G. (2001). "Persistent Sexual Arousal Syndrome: A Newly Discovered Pattern of Female Sexuality". Journal of Sex & Marital Therapy. 27 (4): 365–380. doi:10.1080/009262301317081115. PMID 11441520. S2CID 216088649.
  19. Leiblum, Sandra (September–October 1999). "Sexual problems and dysfunction: epidemiology, classification and risk factors". Journal of Gender-Specific Medicine. 2 (5): 41–45. PMID 11252834.
  20. Markos, A. R.; Dinsmore, Wallace (November 2013). "Persistent genital arousal and restless genitalia: sexual dysfunction or subtype of vulvodynia?". International Journal of STD & AIDS. 24 (11): 852–858. doi:10.1177/0956462413489276. ISSN 1758-1052. PMID 23970620. S2CID 25460597.
  21. "PGAD, GPD". www.smsna.org.
  22. Goldmeier, David; Leiblum, Sandra R. (April 2006). "Persistent genital arousal in women -- a new syndrome entity". International Journal of STD & AIDS. 17 (4): 215–216. doi:10.1258/095646206776253480. ISSN 0956-4624. PMID 16595040. S2CID 38012437.
  23. Jackowich, Robyn A.; Pink, Leah; Gordon, Allan; Pukall, Caroline F. (October 2016). "Persistent Genital Arousal Disorder: A Review of Its Conceptualizations, Potential Origins, Impact, and Treatment". Sexual Medicine Reviews. 4 (4): 329–342. doi:10.1016/j.sxmr.2016.06.003. ISSN 2050-0521. PMID 27461894.
  24. "Effective Healthcare Program". effectivehealthcare.ahrq.gov.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.